Trial Bank
13 trials match
- Aerobic Exercise for Remyelination in Multiple Sclerosis
MSMS (type not specified)Not a drug-phase studyCompleted
Oregon Health and Science University · 2021 · 60 participants
- The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
MSRelapsing MSNot a drug-phase studyRecruiting
SetPoint Medical Corporation · 2026 · 60 participants
- Study to Investigate Vagus Nerve Stimulation Paired With Motor Task for Remyelination and Functional Recovery
MSRelapsing MSNot a drug-phase studyEnrolling by invitation
University of Colorado, Denver · 2025 · 70 participants
- REMYELIKIDS: Exploring Cortical Remyelination in Children With Multiple Sclerosis
MSRelapsing MSNot a drug-phase studyRecruiting
Assistance Publique - Hôpitaux de Paris · 2022 · 40 participants
- CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy
MSRelapsing MSPhase 2Completed
metformin · Cambridge University Hospitals NHS Foundation Trust · 2022 · 70 participants
- MACSiMiSE-BRAIN_v1.0: Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration
MSProgressive MSPhase 2Running, not recruiting
metformin · University Hospital, Antwerp · 2023 · 120 participants
- Demyelination and Remyelination in Multiple Sclerosis (MS) Detected by Brain Amyloid PET-CT
MSRelapsing MSNot a drug-phase studyCompleted
Istituti Clinici Scientifici Maugeri SpA · 2021 · 6 participants
- CLAREMI: Effects of Oral Cladribine on Remyelination and Inflammation in Multiple Sclerosis Patients
MSRelapsing MSPhase 4Status unknown
cladribine · Pontificia Universidade Católica do Rio Grande do Sul · 2021 · 10 participants
- SMARTinMS: Remyelination in Multiple Sclerosis: a PET-MR Longitudinal Study Investigating Individual Profiles of Myelin Repair and the Contribution of Neuroinflammation
MSRelapsing and progressiveNot a drug-phase studyStatus unknown
Assistance Publique - Hôpitaux de Paris · 2022 · 80 participants
- VISIONARY-MS: Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis
MSRelapsing MSPhase 2Terminated
Clene Nanomedicine · 2018 · 73 participants
- ONSTIM: Effect of Transorbital Electrical STIMulation of Optic Nerve on Remyelination After an Acute Optic Neuritis
MSOptic neuritisRelapsing MSNot a drug-phase studyStatus unknown
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts · 2019 · 45 participants
- MST3K: Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study
MSMS (type not specified)Phase 1Completed
liothyronine · Oregon Health and Science University · 2016 · 15 participants
- rhGH in MS: Pilot trial of recombinant human growth hormone for remyelination in multiple sclerosis
MSRelapsing MSPhase 2Completed
somatropin · University of Leipzig · 2007 · 30 participants
About this data
Where the data comes from
ClinicalTrials.gov, the EU Clinical Trials Register, ISRCTN, ChEMBL and Europe PMC, combined into the MSFrontier trial bank.
How it is collected
Registry records are collected automatically, duplicate records across registries are merged, and treatments, phases and populations are tagged by software from the registry data. When an error is reported, we fix the rule so the fix applies to every trial, and log it in the Corrections log.
Last update
Trial bank updated recently. Sources and corrections
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error